Circumcision and the risk of prostate cancer

Cancer

Volumn 118, Issue 18, 2012, Pages 4437-4443

  Wright, Jonathan L ^a,b   Lin, Daniel W ^a,b   Stanford, Janet L ^b,c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER REGISTRY; CANCER RISK; CANCER STAGING; CARCINOGENESIS; CIRCUMCISION; CONTROLLED STUDY; GLEASON SCORE; HUMAN; INFECTION; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATITIS; RISK REDUCTION; SELF REPORT; SEXUAL INTERCOURSE; SEXUALLY TRANSMITTED DISEASE;

ADULT; AGED; CASE-CONTROL STUDIES; CIRCUMCISION, MALE; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; PROSTATITIS; RISK FACTORS; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASES;

EID: 84865976284     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26653     Document Type: Article

References (56)

1. Goktas S, Yilmaz MI, Caglar K, Sonmez A, Kilic S, Bedir S,. Prostate cancer and adiponectin. Urology. 2005; 65: 1168-1172.
2. Huang JQ, Sridhar S, Chen Y, Hunt RH,. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology. 1998; 114: 1169-1179.
3. Yu MW, Chen CJ,. Hepatitis B and C viruses in the development of hepatocellular carcinoma. Crit Rev Oncol Hematol. 1994; 17: 71-91.
4. Mostafa MH, Sheweita SA, O'Connor PJ,. Relationship between schistosomiasis and bladder cancer. Clin Microbiol Rev. 1999; 12: 97-111.
5. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999; 189: 12-19.
6. Backes DM, Kurman RJ, Pimenta JM, Smith JS,. Systematic review of human papillomavirus prevalence in invasive penile cancer. Cancer Causes Control. 2009; 20: 449-457.
7. Dalton-Griffin L, Kellam P,. Infectious causes of cancer and their detection. J Biol. 2009; 8: 67.
8. De Marzo AM, Platz EA, Sutcliffe S, et al. Inflammation in prostate carcinogenesis. Nat Rev Cancer. 2007; 7: 256-269.
9. Dennis LK, Lynch CF, Torner JC,. Epidemiologic association between prostatitis and prostate cancer. Urology. 2002; 60: 78-83.
10. Rothman I, Stanford JL, Kuniyuki A, Berger RE,. Self-report of prostatitis and its risk factors in a random sample of middle-aged men. Urology. 2004; 64: 876-879.
11. De Marzo AM, Marchi VL, Epstein JI, Nelson WG,. Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. Am J Pathol. 1999; 155: 1985-1992.
12. Wang W, Bergh A, Damber JE,. Morphological transition of proliferative inflammatory atrophy to high-grade intraepithelial neoplasia and cancer in human prostate. Prostate. 2009; 69: 1378-1386.
13. Klein EA, Silverman R,. Inflammation, infection, and prostate cancer. Curr Opin Urol. 2008; 18: 315-319.
14. Dennis LK, Coughlin JA, McKinnon BC, et al. Sexually transmitted infections and prostate cancer among men in the U.S. military. Cancer Epidemiol Biomarkers Prev. 2009; 18: 2665-2671.
15. Martinez-Fierro ML, Leach RJ, Gomez-Guerra L, et al. Identification of viral infections in the prostate and evaluation of their association with cancer. BMC Cancer. 2010; 10: 326.
16. Sutcliffe S, Giovannucci E, Alderete JF, et al. Plasma antibodies against Trichomonas vaginalis and subsequent risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. May 2006; 15: 939-945.
17. Taylor ML, Mainous AG 3rd, Wells BJ,. Prostate cancer and sexually transmitted diseases: a meta-analysis. Fam Med. 2005; 37: 506-512.
18. Rosenblatt KA, Wicklund KG, Stanford JL,. Sexual factors and the risk of prostate cancer. Am J Epidemiol. 2001; 153: 1152-1158.
19. La Vecchia C, Franceschi S, Talamini R, Negri E, Boyle P, D'Avanzo B,. Marital status, indicators of sexual activity and prostatic cancer. J Epidemiol Community Health. 1993; 47: 450-453.
20. Oishi K, Okada K, Yoshida O, et al. A case-control study of prostatic cancer in Kyoto, Japan: sexual risk factors. Prostate. 1990; 17: 269-279.
21. Casey G, Neville PJ, Plummer SJ, et al. RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases. Nat Genet. 2002; 32: 581-583.
22. Urisman A, Molinaro RJ, Fischer N, et al. Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog. 2006; 2 (3): e25.
23. Hong S, Klein EA, Das Gupta J, et al. Fibrils of prostatic acid phosphatase fragments boost infections with XMRV (xenotropic murine leukemia virus-related virus), a human retrovirus associated with prostate cancer. J Virol. 2009; 83: 6995-7003.
24. Cook LS, Koutsky LA, Holmes KK,. Circumcision and sexually transmitted diseases. Am J Public Health. 1994; 84: 197-201.
25. Diseker RA 3rd, Peterman TA, Kamb ML, et al. Circumcision and STD in the United States: cross sectional and cohort analyses. Sex Transm Infect. 2000; 76: 474-479.
26. Fergusson DM, Boden JM, Horwood LJ,. Circumcision status and risk of sexually transmitted infection in young adult males: an analysis of a longitudinal birth cohort. Pediatrics. 2006; 118: 1971-1977.
27. Siegfried N, Muller M, Deeks JJ, Volmink J,. Male circumcision for prevention of heterosexual acquisition of HIV in men. Cochrane Database Syst Rev. 2009; 2009 (2): CD003362.
28. Ewings P, Bowie C,. A case-control study of cancer of the prostate in Somerset and east Devon. Br J Cancer. 1996; 74: 661-666.
29. Ross RK, Shimizu H, Paganini-Hill A, Honda G, Henderson BE,. Case-control studies of prostate cancer in blacks and whites in southern California. J Natl Cancer Inst. 1987; 78: 869-874.
30. Ravich A, Ravich RA,. Prophylaxis of cancer of the prostate, penis, and cervix by circumcision. N Y State J Med. 1951; 51: 1519-1520.
31. Stanford JL, Wicklund KG, McKnight B, Daling JR, Brawer MK,. Vasectomy and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 1999; 8: 881-886.
32. Agalliu I, Salinas CA, Hansten PD, Ostrander EA, Stanford JL,. Statin use and risk of prostate cancer: results from a population-based epidemiologic study. Am J Epidemiol. 2008; 168: 250-260.
33. Blauvelt A,. The role of human herpesvirus 8 in the pathogenesis of Kaposi's sarcoma. Adv Dermatol. 1999; 14: 167-206.
34. Krieger JN, Riley DE,. Chronic prostatitis: Charlottesville to Seattle. J Urol. 2004; 172: 2557-2560.
35. Montgomery JD, Jacobson LP, Dhir R, Jenkins FJ,. Detection of human herpesvirus 8 (HHV-8) in normal prostates. Prostate. 2006; 66: 1302-1310.
36. Smith DM, Kingery JD, Wong JK, Ignacio CC, Richman DD, Little SJ,. The prostate as a reservoir for HIV-1. AIDS. 2004; 18: 1600-1602.
37. Zambrano A, Kalantari M, Simoneau A, Jensen JL, Villarreal LP,. Detection of human polyomaviruses and papillomaviruses in prostatic tissue reveals the prostate as a habitat for multiple viral infections. Prostate. 2002; 53: 263-276.
38. Brodine SK, Shafer MA, Shaffer RA, et al. Asymptomatic sexually transmitted disease prevalence in four military populations: application of DNA amplification assays for Chlamydia and gonorrhea screening. J Infect Dis. 1998; 178: 1202-1204.
39. Ross JD, Brown L, Saunders P, Alexander S,. Mycoplasma genitalium in asymptomatic patients: implications for screening. Sex Transm Infect. 2009; 85: 436-437.
40. Handsfield HH, Lipman TO, Harnisch JP, Tronca E, Holmes KK,. Asymptomatic gonorrhea in men. Diagnosis, natural course, prevalence and significance. N Engl J Med. 1974; 290: 117-123.
41. Honda GD, Bernstein L, Ross RK, Greenland S, Gerkins V, Henderson BE,. Vasectomy, cigarette smoking, and age at first sexual intercourse as risk factors for prostate cancer in middle-aged men. Br J Cancer. 1988; 57: 326-331.
42. Sarma AV, McLaughlin JC, Wallner LP, et al. Sexual behavior, sexually transmitted diseases and prostatitis: the risk of prostate cancer in black men. J Urol. 2006; 176: 1108-1113.
43. Schlaberg R, Choe DJ, Brown KR, Thaker HM, Singh IR,. XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors. Proc Natl Acad Sci U S A. 2009; 106: 16351-16356.
44. Dong B, Silverman RH,. Androgen stimulates transcription and replication of xenotropic murine leukemia virus-related virus. J Virol. 2010; 84: 1648-1651.
45. Tobian AA, Serwadda D, Quinn TC, et al. Male circumcision for the prevention of HSV-2 and HPV infections and syphilis. N Engl J Med. 2009; 360: 1298-1309.
46. Weiss HA, Thomas SL, Munabi SK, Hayes RJ,. Male circumcision and risk of syphilis, chancroid, and genital herpes: a systematic review and meta-analysis. Sex Transm Infect. 2006; 82: 101-109.
47. Xu F, Markowitz LE, Sternberg MR, Aral SO,. Prevalence of circumcision and herpes simplex virus type 2 infection in men in the United States: the National Health and Nutrition Examination Survey (NHANES), 1999-2004. Sex Transm Dis. 2007; 34: 479-484.
48. Apt A,. Circumcision and prostatic cancer. Acta Med Scand. 1965; 178: 493-504.
49. Mandel JS, Schuman LM,. Sexual factors and prostatic cancer: results from a case-control study. J Gerontol. 1987; 42: 259-264.
50. Rotkin ID,. Studies in the epidemiology of prostatic cancer: expanded sampling. Cancer Treat Rep. 1977; 61: 173-180.
51. Wynder EL, Mabuchi K, Whitmore WF Jr,. Epidemiology of cancer of the prostate. Cancer. 1971; 28: 344-360.
52. Larke NL, Thomas SL, dos Santos Silva I, Weiss HA,. Male circumcision and penile cancer: a systematic review and meta-analysis. Cancer Causes Control. 2011; 22: 1097-1110.
53. Parker SW, Stewart AJ, Wren MN, Gollow MM, Straton JA,. Circumcision and sexually transmissible disease. Med J Aust. 1983; 2: 288-290.
54. Templeton DJ, Mao L, Prestage GP, Jin F, Kaldor JM, Grulich AE,. Self-report is a valid measure of circumcision status in homosexual men. Sex Transm Infect. 2008; 84: 187-188.
55. Laumann EO, Masi CM, Zuckerman EW,. Circumcision in the United States. Prevalence, prophylactic effects, and sexual practice. JAMA. 1997; 277: 1052-1057.
56. Dennis LK, Ritchie JM, Resnick MI,. Prostate cancer and consistency of reporting sexual histories in men over age 50. Prostate Cancer Prostatic Dis. 2005; 8: 243-247.